-
Treating a Rare Gastrointestinal Cancer: Meeghan DeCagna’s Story
When Meeghan DeCagna was diagnosed with a rare GI cancer, called a GIST, and targeted therapy was unsuccessful, her only option was surgery to remove a six pound tumor. She found Director of Surgical Oncology at MedStar Georgetown, Waddah Al-Refaie, MD to lead her complicated operation.
Category: News
-
Current Role of Chemotherapy in GI and Colorectal Cancer
John L. Marshall, MD, discusses the use of chemotherapy in patients with colorectal (CRC) or other gastrointestinal (GI) cancers
Category: News
-
Liver Cancer Deaths Rise, Along with Hope for Better Treatments
Aiwu Ruth He, MD, PhD, an associate professor at Georgetown Lombardi Comprehensive Cancer Center, is working with colleagues on research into ways to stem rising liver cancer death rates.
Category: News
-
Advanced Pancreatic Cancer: The Road to Personalized Care
In this OncLive® Peer Exchange®, an amazing panel of experts in the field of gastrointestinal oncology provide you with a perspective on recent pancreatic cancer advances and what they mean to the care of your patients for weeks ahead.
Category: News
-
The Rising Incidence of Early-Onset CRC: What Do We Know and What Can We Do?
During an OncLive Peer Exchange® program on individualizing treatment and improving outcomes for patients with CRC, a panel of experts shared their insights on early-onset CRC, which has been observed to occur as early as adolescence.
Category: News
-
Experts Anticipate a Growing Menu of Frontline Options in Liver Cancer
Panelists review data for lenvatinib (Lenvima), and novel drugs under investigation in the second line for HCC, such as cabozantinib (Cabometyx/Cometriq) and pembrolizumab (Keytruda).
Category: News
-
Not All Pancreatic Cancers are the Same: Some Have Treatable Mutations
There are subgroups of patients with pancreatic cancer whose tumors are particularly susceptible to certain therapies.
Category: News
-
Marshall Makes the Case for Molecular Sorting in Gastrointestinal Disease
Oncologists have been slow to introduce targeted and immune therapies into the treatment of gastrointestinal cancers, but that is changing, and poor patient survival statistics call for a continuation of this trend.
Category: News
-
Aligning Effective Treatments and Communication to Optimize Care of Patients With Metastatic Colorectal Cancer
Learn how John L. Marshall, MD, and Bobbie Khan, MS, RN, OCN, involve patients with metastatic colorectal cancer in their own care in order to provide optimal treatment.
Category: News
-
Advancing Care Across the Spectrum of Pancreatic Cancer
How are recent advances in treatment of pancreatic cancer affecting patient outcomes?
Category: News